Apple's AI discovery leads to new blood pressure notification on Watch.

Apple has used AI to discover a new feature on its Watch that can detect and notify users of high blood pressure. The company is specializing in computer hardware and music support, with net sales distributed across various product categories and geographic regions.

Apple Inc. (AAPL) has announced the FDA approval of its new hypertension notification feature on the Apple Watch Ultra 3. The feature, which uses advanced machine learning algorithms to analyze heart rate data, will notify users if it detects consistent signs of hypertension. This marks a significant step in Apple's ongoing efforts to incorporate health monitoring capabilities into its wearable devices.

The new feature, which will be available on Apple Watch Series 9 and later, as well as Apple Watch Ultra 2 and later, uses data from the optical heart sensor to monitor blood vessel responses to heartbeats over a 30-day period. The algorithm, developed with over 100,000 participants in multiple studies, will notify users if it detects signs of hypertension. While it may not detect all instances of hypertension, the reach of Apple Watch is expected to notify over 1 million people with undiagnosed hypertension within the first year.

The feature will be available in over 150 countries and regions, including the U.S. and the EU, starting this month. It will be integrated into watchOS 26, which begins rolling out on September 15. Apple shares were up 1.81% at $234.19 at the time of publication on Friday, trading within its 52-week range of $169.21 to $260.10 FDA Gives Green Light To Hypertension Alerts On Apple Watch^[1].

This approval underscores Apple's commitment to health and wellness, further diversifying its product offerings and expanding its market reach. The integration of health monitoring features into its wearable devices positions Apple as a leader in the health tech sector, potentially opening up new revenue streams and enhancing user engagement.